GDH-PQQ Glucose Test Strips May Produce Falsely Elevated Results
The U.S. Food and Drug Administration has notified health care professionals of the potential for falsely elevated blood glucose results with the use of glucose dehydrogenase pyrroloquinoline quinone (GDH-PQQ) glucose test strips in patients receiving products containing certain nonglucose sugars.
The FDA's safety information and adverse event reporting program found that the GDH-PQQ test cannot distinguish between glucose and other sugars and can "falsely elevate glucose results, which may mask significant hypoglycemia or prompt excessive insulin administration, leading to serious injury or death."
Back to News
